Postpartum Hemorrhage: Moving from Research to Reality

Gynuity and partners have been working since 2004 on a program of research with support from the Bill & Melinda Gates Foundation to help establish the safety, efficacy, and appropriateness of misoprostol for prevention and treatment of postpartum hemorrhage (PPH) in a variety of clinical settings. In 2009, in collaboration with partners, Gynuity embarked on a follow-up initiative to answer remaining research questions, address operational and service-delivery issues related to misoprostol’s applications including at the community-level, and influence policies and clinical practice guidelines to better reflect the evidence and promote appropriate use. This project description provides results of the initiative to date and planned activities under the new grant.